Multiple lawsuits are outstanding against Johnson & Johnson Pharmaceuticals and Janssen Pharmaceuticals after patients taking Elmiron developed permanent retinal injuries.
Elmiron, which is used to treat interstitial cystitis, is also known as pentosan polysulfate sodium (PPS). Individuals currently taking Elmiron should obtain an eye examination.
The pharmaceutical companies have yet to release a statement on the apparent connection between the drug and maculopathy.
Source: The National Law Review